BRICS leaders call for stronger cooperation in disease surveillance, medical product regulation
In their New Delhi Declaration, the leaders stressed the importance of strengthening health infrastructure and local production of medical products to enhance preparedness for future health emergencies and ensure timely, affordable and equitable access to healthcare services, vaccines, therapeutics and diagnostics
On September 12, 2026, leaders of the BRICS nations urged for enhanced cooperation in disease surveillance and medical product regulation, endorsing the creation of a specialized sub-working group to develop an integrated early warning system for preventing and responding to mass infectious diseases. In their New Delhi Declaration, the leaders emphasized the significance of fortifying health infrastructure and domestic production of medical products to bolster readiness for future health crises and guarantee timely, affordable, and equitable access to healthcare services, vaccines, therapeutic agents, and diagnostic tools.
They also advocated for heightened collaboration among BRICS medical products regulatory authorities and welcomed endeavors to formulate a unified GxP white paper encapsulating regulatory best practices and technical methodologies. The leaders acknowledged that infectious disease outbreaks, zoonotic threats, antimicrobial resistance, and other public health crises know no national boundaries and necessitate intensified international cooperation, prompt information exchange, and synchronized efforts.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- BRICS leaders call for stronger cooperation in disease surveillance, medical product regulation thehindu.com
- BRICS countries call for stronger cooperation in health, endorse initiatives on TB health.economictimes.indiatimes.com
